Ruschitzka F - Search Results

1

The subcutaneous implantable cardioverter defibrillator in daily clinical practice.

Özkartal T, Breitenstein A, Saguner AM, Inderbitzin DT, Wilhelm M, Benussi S, Maisano F, Lüscher TF, Ruschitzka F, Steffel J. Özkartal T, et al. Among authors: ruschitzka f. Swiss Med Wkly. 2017 Oct 22;147:w14518. doi: 10.4414/smw.2017.14518. eCollection 2017. Swiss Med Wkly. 2017. PMID: 29120016 Free article.

2

Endothelin: culprit or bystander in Addison's disease?

Ruschitzka FT, Lüscher TF. Ruschitzka FT, et al. Eur J Endocrinol. 1996 Dec;135(6):645-8. doi: 10.1530/eje.0.1350645. Eur J Endocrinol. 1996. PMID: 9025703 No abstract available.

3

Different effects of thrombin receptor activation on endothelium and smooth muscle cells of human coronary bypass vessels. Implications for venous bypass graft failure.

Yang Z, Ruschitzka F, Rabelink TJ, Noll G, Julmy F, Joch H, Gafner V, Aleksic I, Althaus U, Lüscher TF. Yang Z, et al. Among authors: ruschitzka f. Circulation. 1997 Apr 1;95(7):1870-6. doi: 10.1161/01.cir.95.7.1870. Circulation. 1997. PMID: 9107175

4

Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?

Ruschitzka FT, Lüscher TF. Ruschitzka FT, et al. Am Heart J. 1997 Aug;134(2 Pt 2):S31-47. doi: 10.1016/s0002-8703(97)70007-3. Am Heart J. 1997. PMID: 9313622 Review.

5

The endothelium in coronary artery disease.

Ruschitzka FT, Noll G, Lüscher TF. Ruschitzka FT, et al. Cardiology. 1997;88 Suppl 3:3-19. doi: 10.1159/000177500. Cardiology. 1997. PMID: 9397288 Review.

6

Combination of ACE inhibitors and calcium antagonists: a logical approach.

Ruschitzka FT, Noll G, Lüscher TF. Ruschitzka FT, et al. J Cardiovasc Pharmacol. 1998;31 Suppl 2:S5-16. doi: 10.1097/00005344-199800002-00002. J Cardiovasc Pharmacol. 1998. PMID: 9605596 Review.

7

[Calcium antagonists. Results of recent studies and their significance for general practice].

Ruschitzka FT, Noll G, Lüscher TF. Ruschitzka FT, et al. Internist (Berl). 1999 Feb;40(2):225-34. doi: 10.1007/s001080050327. Internist (Berl). 1999. PMID: 10097989 Review. German. No abstract available.

8

Endothelial dysfunction in acute renal failure: role of circulating and tissue endothelin-1.

Ruschitzka F, Shaw S, Gygi D, Noll G, Barton M, Lüscher TF. Ruschitzka F, et al. J Am Soc Nephrol. 1999 May;10(5):953-62. doi: 10.1681/ASN.V105953. J Am Soc Nephrol. 1999. PMID: 10232680

9

A rationale for treatment of endothelial dysfunction in hypertension.

Ruschitzka F, Corti R, Noll G, Lüscher TF. Ruschitzka F, et al. J Hypertens Suppl. 1999 Feb;17(1):S25-35. J Hypertens Suppl. 1999. PMID: 10340841 Review.

10

Angiotensin converting enzyme inhibitors and vascular protection in hypertension.

Ruschitzka F, Noll G, Lüscher TF. Ruschitzka F, et al. J Cardiovasc Pharmacol. 1999 Aug;34 Suppl 1:S3-12. doi: 10.1097/00005344-199908001-00002. J Cardiovasc Pharmacol. 1999. PMID: 10499558 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

608 results

Search Page

Filters